[Clinical results on the application of the new antiphlogistic preparation, G-27202 (Tanderil) in ocular diseases].
D005123:Eye; D006257:Head; D009132:Muscles; D009885:Ophthalmology / Q000628:therapy*; D010113:Oxyphenbutazone; D010653:Phenylbutazone / Q000031:analogs & derivatives
D010653:Phenylbutazone; D010113:Oxyphenbutazone
OPHTHALMOLOGY/therapy; PHENYLBUTAZONE/related compounds